Chordate and Nanos Medical concludes Joint venture for China 2018-05-24

Press Release Chordate and Nanos Medical concludes Joint venture for China Kista-Shanghai, 24 May 2018. Chordate Medical Holding AB (publ) (“Chordate”) has, through its subsidiary Chordate Medical AB, signed an agreement of co-ownership of a newly registered Shanghai-based company in a Joint venture with Nanos Medical (Shanghai) Limited (‘ Nanos Medical ‘), primarily concerning the Chinese market. Nanos Medical invests MUSD 1.5 for about 67 […]

EUFOREA’s RHINOLOGY FUTURE DEBATES 2018-05-16

Watch EUFOREA’s rhinology future debate held on 8th of December 2017. Chordate takes part in ‘Nasal turbinate as therapeutic target’ http://www.youtube.com/watch?time_continue=20&v=YHTE_zbgyDw/

Chordate enrolls first patients in a randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy of intranasal kinetic oscillation stimulation in the treatment of chronic non-allergic rhinitis 2018-05-08

Chordate enrolls first patients in a randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy of intranasal kinetic oscillation stimulation in the treatment of chronic non-allergic rhinitis Data Anticipated Q4 2019 Kista, Sweden, May 08, 2018 — Chordate Medical Holding AB’s (publ) (“Chordate”), a specialty medtech company that focuses on developing and commercializing neuromodulating treatment systems for treating non-allergic rhinitis and migraine, today announced that […]